Mark Chandy

1.8k total citations
27 papers, 1.1k citations indexed

About

Mark Chandy is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Mark Chandy has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pharmacology. Recurrent topics in Mark Chandy's work include Genomics and Chromatin Dynamics (5 papers), Pluripotent Stem Cells Research (3 papers) and Cannabis and Cannabinoid Research (3 papers). Mark Chandy is often cited by papers focused on Genomics and Chromatin Dynamics (5 papers), Pluripotent Stem Cells Research (3 papers) and Cannabis and Cannabinoid Research (3 papers). Mark Chandy collaborates with scholars based in United States, Canada and Singapore. Mark Chandy's co-authors include Jerry L. Workman, Michael J. Carrozza, Philippe Prochasson, Joseph C. Wu, Ahmed H. Hassan, Kristen E. Neely, Scott Galasinski, David T. Paik, José L. Gutiérrez and David K. Gifford and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Mark Chandy

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Chandy United States 13 950 113 81 73 59 27 1.1k
Guanghui Cui China 18 431 0.5× 47 0.4× 139 1.7× 40 0.5× 25 0.4× 51 783
Takashi Shimada Japan 13 392 0.4× 70 0.6× 20 0.2× 140 1.9× 23 0.4× 21 567
Xuebin Zhang China 15 536 0.6× 143 1.3× 42 0.5× 23 0.3× 18 0.3× 32 767
Ulrike Bönisch Germany 8 405 0.4× 42 0.4× 55 0.7× 63 0.9× 22 0.4× 16 641
Xiaojun Chen China 13 233 0.2× 28 0.2× 60 0.7× 124 1.7× 23 0.4× 46 596
Dingyuan Ma China 14 504 0.5× 30 0.3× 60 0.7× 177 2.4× 48 0.8× 55 775
Seokho Kim South Korea 17 479 0.5× 20 0.2× 114 1.4× 190 2.6× 45 0.8× 43 811
Eric J. Askeland United States 9 309 0.3× 58 0.5× 110 1.4× 21 0.3× 38 0.6× 10 626
J C Kandala United States 10 475 0.5× 29 0.3× 150 1.9× 197 2.7× 28 0.5× 16 883

Countries citing papers authored by Mark Chandy

Since Specialization
Citations

This map shows the geographic impact of Mark Chandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Chandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Chandy more than expected).

Fields of papers citing papers by Mark Chandy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Chandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Chandy. The network helps show where Mark Chandy may publish in the future.

Co-authorship network of co-authors of Mark Chandy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Chandy. A scholar is included among the top collaborators of Mark Chandy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Chandy. Mark Chandy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wenqiang, Xuekun Wu, Wenshu Zeng, Mark Chandy, & Joseph C. Wu. (2025). Cardiac fibrosis: from mechanisms and models to medicines. Trends in Pharmacological Sciences. 46(11). 1072–1090. 2 indexed citations
2.
Chandy, Mark, et al.. (2025). The relationship between cannabis and cardiovascular disease: clearing the haze. Nature Reviews Cardiology. 22(7). 467–481. 9 indexed citations
3.
Yin, Hao, et al.. (2025). Harnessing iPSCs to Model Marfan Syndrome: Advancing Clinical Diagnosis and Drug Discovery. Current Treatment Options in Cardiovascular Medicine. 27(1). 2 indexed citations
4.
Chandy, Mark, Thomas Hill, Joseph C. Wu, et al.. (2024). Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”. Cardiovascular Toxicology. 24(5). 435–471. 1 indexed citations
5.
Abazid, Rami M., et al.. (2024). Role of myocardial strain imaging in diagnosing inducible myocardial ischemia with treadmill contrast-enhanced stress echocardiography. BMC Cardiovascular Disorders. 24(1). 254–254. 1 indexed citations
6.
Chandy, Mark, et al.. (2023). Exosomes and lipid metabolism in metabolic and cardiovascular disorders. Current Opinion in Lipidology. 34(2). 82–91. 9 indexed citations
7.
Chandy, Mark, Detlef Obal, & Joseph C. Wu. (2022). Elucidating effects of environmental exposure using human‐induced pluripotent stem cell disease modeling. EMBO Molecular Medicine. 14(11). e13260–e13260. 22 indexed citations
8.
Rhee, Siyeon, David T. Paik, Ian M. Williams, et al.. (2021). Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compaction. European Heart Journal. 42(41). 4264–4276. 41 indexed citations
9.
Chandy, Mark, Juan Aguilera, Eric Smith, et al.. (2021). Adverse effects of air pollution‐derived fine particulate matter on cardiovascular homeostasis and disease. Trends in Cardiovascular Medicine. 32(8). 487–498. 19 indexed citations
10.
Chour, Tony, Lei Tian, Edward Lau, et al.. (2021). Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies. JCI Insight. 6(7). 15 indexed citations
11.
Paik, David T., Mark Chandy, & Joseph C. Wu. (2019). Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics. Pharmacological Reviews. 72(1). 320–342. 137 indexed citations
12.
Chandy, Mark, Masayoshi Ishida, Eric A. Shikatani, et al.. (2018). c-Myb regulates transcriptional activation of miR-143/145 in vascular smooth muscle cells. PLoS ONE. 13(8). e0202778–e0202778. 10 indexed citations
13.
Gandhi, Sumeet, et al.. (2013). Successful rapid intravenous desensitization for radioiodine contrast allergy in a patient requiring urgent coronary angiography. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 101–102. 14 indexed citations
14.
Gutiérrez, José L., Mark Chandy, Michael J. Carrozza, & Jerry L. Workman. (2007). Activation domains drive nucleosome eviction by SWI/SNF. The EMBO Journal. 26(3). 730–740. 70 indexed citations
15.
Chandy, Mark, José L. Gutiérrez, Philippe Prochasson, & Jerry L. Workman. (2006). SWI/SNF Displaces SAGA-Acetylated Nucleosomes. Eukaryotic Cell. 5(10). 1738–1747. 73 indexed citations
16.
Pattenden, Samantha G., Mark Chandy, José L. Gutiérrez, & Jerry L. Workman. (2005). Chromatin dynamics rule the genome.. Genome Biology. 6(11). 355–355. 3 indexed citations
17.
Robert, François, Dmitry Pokholok, Nancy M. Hannett, et al.. (2004). Global Position and Recruitment of HATs and HDACs in the Yeast Genome. Molecular Cell. 16(2). 199–209. 198 indexed citations
18.
Jerónimo, Celia, Marie-France Langelier, Mahel Zeghouf, et al.. (2004). RPAP1, a Novel Human RNA Polymerase II-Associated Protein Affinity Purified with Recombinant Wild-Type and Mutated Polymerase Subunits. Molecular and Cellular Biology. 24(16). 7043–7058. 59 indexed citations
19.
Hassan, Ahmed H., Philippe Prochasson, Kristen E. Neely, et al.. (2002). Function and Selectivity of Bromodomains in Anchoring Chromatin-Modifying Complexes to Promoter Nucleosomes. Cell. 111(3). 369–379. 400 indexed citations
20.
Liu, Dong, Mark Chandy, Soo‐Kyung Lee, et al.. (2000). A Zebrafish Ftz-F1 (Fushi Tarazu Factor 1) Homologue Requires Multiple Subdomains in the D and E Regions for Its Transcriptional Activity. Journal of Biological Chemistry. 275(22). 16758–16766. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guanghui Cui Breakdown of academic impact, for papers by Takashi Shimada Breakdown of academic impact, for papers by Xuebin Zhang Breakdown of academic impact, for papers by Ulrike Bönisch Breakdown of academic impact, for papers by Xiaojun Chen Breakdown of academic impact, for papers by Dingyuan Ma Breakdown of academic impact, for papers by Seokho Kim Breakdown of academic impact, for papers by Eric J. Askeland Breakdown of academic impact, for papers by J C Kandala
Rankless by CCL
2026